Corrigendum

Abstract

CorrigendumCorrigendumPublished Online:15 Feb 2014https://doi.org/10.1152/ajpgi.zh3-6611-corr.2014Original articleMoreSectionsPDF (29 KB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations ShareShare onFacebookTwitterLinkedInEmailWeChat Volume 306, January 2014Volume 69, January 2014Bailey AM, et al. FXR silencing in human colon cancer by DNA methylation and KRAS signaling. Am J Physiol Gastrointest Liver Physiol 306: G48–G58, 2014. doi: 10.1152/ajpgi.00234.2013The author list and credits section for this article were incomplete as published. The corrected sections appear below, and the article has been corrected online.Ann M. Bailey,1,2 Le Zhan,2,10 Dipen Maru,3 Imad Shureiqi,4 Curtis R. Pickering,5 Galina Kiriakova,1 Julie Izzo,1 Nan He,6 Caimiao Wei,7 Veerabhadran Baladandayuthapani,7 Han Liang,8 Scott Kopetz,4 Garth Powis,1,9 and Grace L. Guo2,101Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas; 2Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas; 3Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; 4Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas; 5Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas; 6Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas; 7Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas; 8Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas; 9Sanford Burnham Medical Research Institute, Cancer Center, La Jolla, California; and 10Department of Pharmacology and Toxicology, School of Pharmacy, Rutgers University, Piscataway, New JerseyGRANTSThis work was supported by CA172670 (G. Powis), CPRIT Training Grants RP101502 to The University of Texas MD Anderson Cancer Center (A. M. Bailey), DK031343 (G. L. Guo), and DK090036 (G. L. Guo).DISCLOSURESNo conflicts of interest, financial or otherwise, are declared by the author(s).AUTHOR CONTRIBUTIONSA.M.B., L.Z., D.M., I.S., C.R.P., J.I., N.H., C.W., V.B., H.L., S.K., G.P., and G.L.G. conception and design of research; A.M.B., L.Z., and G.K. performed experiments; A.M.B., L.Z., D.M., C.R.P., G.K., C.W., V.B., H.L., G.P., and G.L.G. analyzed data; A.M.B., L.Z., D.M., I.S., G.K., J.I., N.H., C.W., V.B., H.L., S.K., G.P., and G.L.G. interpreted results of experiments; A.M.B., C.R.P., C.W., and G.L.G. prepared figures; A.M.B., C.W., H.L., and G.L.G. drafted manuscript; A.M.B., L.Z., D.M., I.S., C.R.P., G.K., J.I., N.H., C.W., V.B., H.L., S.K., G.P., and G.L.G. edited and revised manuscript; A.M.B., L.Z., D.M., I.S., C.R.P., G.K., J.I., N.H., C.W., V.B., H.L., S.K., G.P., and G.L.G. approved final version of manuscript.ACKNOWLEDGMENTSWe appreciate the help and discussion from Dr. Vadivel Ganapathy at the Medical College of Georgia, and for human colon cancer cell line cDNAs provided by his laboratory. A special thanks goes to the late Dr. Mani Maran Rengasamy for help with animal studies and scientific discussion. We also thank the University of Kansas Cancer Center and University of Kansas Cancer Center Biospecimen Core for pilot grants and human colon samples. We also thank Lynda Corley from the histology core facilities within the Department of Pathology at MD Anderson Cancer Center for assistance and guidance with the analysis and data acquisition of IHC slides. Furthermore, special thanks goes to Dr. Patricia Thompson at the University of Arizona Cancer Center for providing colon tissue microarrays used for this study and research pathologist Dr. Viren R. Patel at MD Anderson Cancer Center for extracting tissue microarrays information necessary for IHC data analysis.This article has no references to display. Download PDF Previous Back to Top FiguresReferencesRelatedInformationRelated ArticlesFXR silencing in human colon cancer by DNA methylation and KRAS signaling 01 Jan 2014American Journal of Physiology-Gastrointestinal and Liver Physiology More from this issue > Video Abstract Volume 306Issue 4February 2014Pages G357-G357 Copyright & PermissionsCopyright © 2014 the American Physiological Societyhttps://doi.org/10.1152/ajpgi.zh3-6611-corr.2014History Published online 15 February 2014 Published in print 15 February 2014 Metrics